Sections

Events

Left Column
Image
Image
class_photo_215x253
Right Column
Text Area

2025-04-28 Class photo taking (2024/25 Fall)

Master of Science in Drug Regulatory Affairs and Policy (DRAP) 2024/25 Cohort Class Photo

On April 28, 2025, the students of 2024/25 cohort and faculty members of the Master of Science in Drug Regulatory Affairs and Policy (DRAP) program at The Hong Kong University of Science and Technology (HKUST) came together to take their official class photo, marking a memorable moment in the program’s inaugural year. 

Left Column
Image
Image
ispe_info_seesion_215x253
Right Column
Text Area

2025-04-23 ISPE Student chapter Sharing Session

MSc DRAP Program and HKUST ISPE Student Chapter Host Career Development Sharing Session in Biomanufacturing 

This event was specially arranged for both MSc DRAP students and undergraduate students from the Division of Life Science. The session aimed to introduce the HKUST ISPE Student Chapters, highlight career opportunities in the pharmaceutical and biomanufacturing industry, and provide valuable insights into career

Left Column
Image
Image
group_215x253
Right Column
Text Area

2025-02-28 DRAP Party

 MSc DRAP program Party

On February 28, 2025, the MSc Drug Regulatory Affairs and Policy (DRAP) program successfully held a vibrant and memorable program party, bringing together students, faculty, and industry guests for an evening of celebration and connection. 

Left Column
Image
Image
BioMed_group_215x253
Right Column
Text Area

2024-11-30 The 9th China BioMed Innovation and Investment Conference

MSc DRAP program students participated in the 9th China BioMed Innovation and Investment Conference

From November 30 to December 1, 2024, students from the MSc DRAP program actively participated in the 9th Pharmaceutical Innovation and Investment Conference held in Guangzhou. This prestigious event, initiated by the China Pharmaceutical Innovation and Research Development Association, is one of the most influential platforms that bridges the pharmaceutical and investment communities in China.